These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10205553)

  • 1. Rheumatology. Part 2: The role of medication.
    Byrne J
    Prof Nurse; 1999 Feb; 14(5):353-8. PubMed ID: 10205553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines.
    Arthritis Rheum; 1996 May; 39(5):723-31. PubMed ID: 8639168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy for patients with rheumatoid arthritis.
    Arthur V
    Br J Nurs; 1995 Jun 8-21; 4(11):616-21. PubMed ID: 7626934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DC-ART: the concept.
    Edmonds J
    J Rheumatol Suppl; 1994 Sep; 41():3-5; discussion 5-7. PubMed ID: 7799382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
    Choy E
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a rheumatology expert nurse on the wellbeing of patients attending a drug monitoring clinic.
    Ryan S; Hassell AB; Lewis M; Farrell A
    J Adv Nurs; 2006 Feb; 53(3):277-86. PubMed ID: 16441532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern drug treatment options for rheumatoid arthritis.
    Binning M
    Aust Nurs J; 2001 Apr; 8(9):suppl 1-3. PubMed ID: 11894377
    [No Abstract]   [Full Text] [Related]  

  • 11. Disease-modifying drugs in rheumatoid arthritis.
    Rahman A; Ahmed S; Underwood M
    Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Development of standards by the Norwegian Society of Rheumatology. Control of disease modifying drugs].
    Kvien TK; Haga HJ; Kvalvik AG
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2315-8. PubMed ID: 8804206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Group for the Respect of Ethics and Excellence in Science (GREES): rheumatoid arthritis section.
    Br J Rheumatol; 1998 Feb; 37(2):211-5. PubMed ID: 9569079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Rheum Dis Clin North Am; 2007 Feb; 33(1):197-217. PubMed ID: 17367700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database.
    Buchbinder R; March L; Lassere M; Briggs AM; Portek I; Reid C; Meehan A; Henderson L; Wengier L; van den Haak R
    Intern Med J; 2007 Sep; 37(9):591-600. PubMed ID: 17573817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Bruce IN; Silman AJ; Symmons DP
    J Rheumatol; 2005 Jan; 32(1):6-10. PubMed ID: 15630715
    [No Abstract]   [Full Text] [Related]  

  • 17. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.
    Bathon JM; Cohen SB
    Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712
    [No Abstract]   [Full Text] [Related]  

  • 18. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Chakravarty K; McDonald H; Pullar T; Taggart A; Chalmers R; Oliver S; Mooney J; Somerville M; Bosworth A; Kennedy T; ;
    Rheumatology (Oxford); 2008 Jun; 47(6):924-5. PubMed ID: 16940305
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheumatoid arthritis. New disease-modifying and anti-inflammatory drugs.
    Infante R; Lahita RG
    Geriatrics; 2000 Mar; 55(3):30-2, 35-6, 39-40. PubMed ID: 10732003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritis: new agents herald more effective symptom management.
    Simon LS
    Geriatrics; 1999 Jun; 54(6):37-42; quiz 44. PubMed ID: 10377916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.